Serum Collection Study for Assay Development
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-69
SponsorGPN Vaccines
About this trial
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Eligibility criteria
Qualifiers
good general health
Disqualifiers
no previous pneumococcal vaccine
Trial design
Treatments tested in this trial
- Gamma-PN
Treatment groups
12 Participants
are divided into 1 treatment groupLocations
1University of Adelaide Clinical Research Facility5000, AdelaideSouth Australia, Australia
Sponsors and collaborators
GPN Vaccines
Lead sponsor
Source ClinicalTrials.gov